Free tool
Rare disease stocks
We cover 2 companies grouped under the Rare disease theme. The median market value in the group is $5.44B. Across the group, the median move over the past trading day is +1.33%. Price change over the past year runs from +14.9% to +101.8% across the middle 80 percent of the group, with a median of +58.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.